explore -WSS

explore

author：fashion 2025-10-02 21:04:32 - browse：8499

Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： American woman, child freed after being kidnapped in Haiti last month

WSS

Drastic changes should bring profitability, startup health insurers say

Sage hopes for a blockbuster in antidepressant now before FDA

The best solution to the drug shortages problem

What to know about Virgin Galactic's 1st mission taking paying customers to space

Vertex non

Wegovy’s successful heart trial raises vital question about weight loss

focus

explore

focus

As demand for Covid shots wanes, Moderna seeks its next success

Mega Millions pot grows to $1.25 billion after no winner

At least 13 dead in Texas as scorching temps continue

NIH trials fail to test meaningful long Covid therapies, experts say

New air purifier tech could be key to improving indoor air quality

NIH launches clinical trials and new research office for long Covid

Psychedelics group wrestles with new pharma identity

South Korea throws huge K

Virginia high school admissions case could be legal follow

American woman, child freed after being kidnapped in Haiti last month

knowledge

5 important ways Henrietta Lacks changed medical science

What to expect as Trump is arraigned on his Jan 6. indictment

Mega Millions pot grows to $1.25 billion after no winner

In same hospitals, Black patients receive fewer opioids than white patients

Mitch McConnell episode has important public health takeaway

For Cytokinetics, FDA rejection of heart drug would help, not hinder

explore

focus

entertainment

explore